Gene Fusion

Oncogenic Fusion Protein Structure Determination

Characterizing three-dimensional structures of cancer-causing fusion proteins using cryo-EM and X-ray crystallography to enable targeted drug design.

RESEARCH GAP FRONTIERS

Chimeric Antigen Receptor Engineering Via Fusion

Designing novel CAR-T cell receptors through strategic gene fusion for enhanced immunotherapy applications in hematologic malignancies.

RESEARCH GAP FRONTIERS

Translocation Breakpoint Mapping Technologies

Developing high-resolution sequencing methods to identify and characterize chromosomal translocation breakpoints underlying gene fusions.

RESEARCH GAP FRONTIERS

Fusion-Driven Transcriptional Dysregulation Mechanisms

Investigating how fusion proteins aberrantly alter chromatin remodeling and transcription factor binding to disrupt normal gene expression.

RESEARCH GAP FRONTIERS

Recurrent Gene Fusion Classification Systems

Establishing standardized taxonomies and nomenclature for cataloging recurrent fusion events across diverse cancer types and tissues.

RESEARCH GAP FRONTIERS

Fusion-Induced Protein Domain Shuffling

Analyzing how fusion events combine functional protein domains to generate novel enzymatic or binding properties in cancer cells.

RESEARCH GAP FRONTIERS

RNA-Level Gene Fusion Detection Methods

Optimizing RNA-seq and RT-PCR protocols for sensitive detection and quantification of fusion transcripts in clinical samples.

RESEARCH GAP FRONTIERS

Therapeutic Targeting Fusion-Specific Epitopes

Developing immunotherapies targeting neo-epitopes exclusively present at gene fusion junctions for precision cancer treatment.

Fusion Gene Expression Regulation Networks

Mapping regulatory elements controlling fusion transcript expression and identifying feedback mechanisms maintaining aberrant signaling.

CRISPR-Based Fusion Gene Ablation

Engineering precise CRISPR systems to selectively target and eliminate fusion transcripts while preserving wild-type alleles.

Kinase Fusion Activation Mechanisms

Elucidating how fusion partners provide constitutive activation domains to normally regulated kinases in leukemia and sarcomas.

Liquid Biopsy Fusion Detection Assays

Developing blood-based circulating cell-free DNA assays for non-invasive detection of gene fusion events in cancer patients.

Fusion-Associated Neoantigens Immunogenicity

Assessing immunological properties of fusion junction-derived neoantigens to predict immunotherapy response in fusion-positive tumors.

Temporal Evolution Gene Fusion Clones

Tracking clonal expansion and evolution of fusion-positive populations over time using single-cell sequencing approaches.

Synthetic Lethal Interactions Fusion Proteins

Identifying genetic and pharmacological vulnerabilities specifically exploitable in cells dependent on fusion protein function.

Three-Way Chromothripsis-Mediated Fusions

Investigating complex gene fusion events arising from chromothripsis involving three or more chromosomal rearrangements.

Fusion Protein Subcellular Localization Dynamics

Determining cellular compartmentalization and trafficking of fusion proteins to understand their functional consequences.

Pediatric-Specific Fusion Gene Landscapes

Characterizing age-dependent fusion profiles and their unique molecular consequences in childhood malignancies.

Fusion-Driven Metabolic Reprogramming

Analyzing metabolic alterations induced by fusion proteins to identify targetable metabolic dependencies.

Isoform-Specific Fusion Transcript Variants

Cataloging alternative splicing patterns generating multiple functional isoforms from single fusion loci.

Protein-Protein Interaction Mapping Fusions

Comprehensively mapping interactomes of fusion proteins to identify novel effector pathways and therapeutic targets.

Fusion-Mediated DNA Damage Response Evasion

Investigating mechanisms by which fusion proteins suppress DNA damage checkpoints and genomic stability pathways.

Tissue-Specific Fusion Predisposition Factors

Identifying chromatin accessibility and structural features determining tissue-specific fusion susceptibility.

High-Order Gene Fusion Complex Structures

Studying multi-fusion events and their assembly into higher-order protein complexes with amplified pathogenic effects.

Resistance Mechanisms Fusion-Targeted Therapies

Characterizing secondary mutations and alternative pathway activation causing resistance to fusion-specific inhibitors.

Long Non-Coding RNA Fusion Transcripts

Investigating fusion events generating functional long non-coding RNAs with oncogenic regulatory properties.

Fusion-Positive Tumor Microenvironment Interactions

Examining how fusion proteins reprogram immune cell infiltration and stromal cell activation within tumors.

Palindromic Fusion Event Mechanisms

Understanding symmetrical chromosomal rearrangements generating inverted fusion configurations.

Fusion Protein Ubiquitination and Degradation

Characterizing post-translational modifications regulating fusion protein stability and proteasomal degradation pathways.

Spatial Genomics Fusion Detection Integration

Combining spatial transcriptomics with fusion detection to map fusion-positive cell populations within tumors.

Fusion-Associated MicroRNA Dysregulation

Investigating aberrant miRNA expression patterns driven by fusion proteins and their tumor-promoting consequences.

Engineered Fusion Proteins Therapeutic Delivery

Designing recombinant fusion proteins as biologics for targeted therapy and immunomodulation applications.

Fusion-Driven Telomerase Reactivation Mechanisms

Elucidating how fusion transcription factors activate telomerase to enable cellular immortalization.

Multiplex Digital PCR Fusion Quantification

Developing highly sensitive multiplexed ddPCR assays for absolute quantification of multiple fusion transcripts simultaneously.

Fusion-Specific Splicing Factor Dependencies

Identifying spliceosome components required for fusion transcript processing as vulnerability targets.

Temporal Genomic Instability Fusion Origins

Reconstructing timelines of genomic events precipitating fusion formation using phylogenetic analysis.

Fusion-Induced Immune Checkpoint Upregulation

Characterizing PD-L1 and other immune checkpoint molecule induction by fusion protein signaling.

Organoid Models Fusion-Driven Tumorigenesis

Generating three-dimensional organoid systems recapitulating fusion-mediated transformation for drug screening.

Fusion Junction Read-Through Translation Products

Investigating alternative translation initiation generating N-terminal truncated fusion variants with distinct properties.

Epigenetic Remodeling Fusion-Dependent

Mapping chromatin modifications and histone marks established by fusion protein-associated chromatin remodelers.

Fusion-Positive Cancer Stem Cell Properties

Characterizing stem cell-like properties and self-renewal pathways enriched in fusion-positive cell populations.

Machine Learning Fusion Detection Optimization

Developing artificial intelligence algorithms to improve fusion discovery sensitivity and specificity from sequencing data.

Fusion-Associated Angiogenic Factor Production

Analyzing VEGF and other angiogenic molecule secretion by fusion-expressing cells to promote vascularization.

Cross-Species Fusion Conservation Patterns

Investigating evolutionary constraints on fusion formation and conservation across mammalian species.

Fusion Protein Phase Separation Properties

Examining biomolecular condensate formation by fusion proteins and consequences for transcriptional control.

Single-Molecule Fusion Protein Dynamics

Using single-molecule fluorescence techniques to observe conformational changes and binding kinetics of fusion proteins.

Fusion-Mediated Apoptosis Resistance Pathways

Characterizing anti-apoptotic mechanisms activated by fusion proteins to suppress cell death.

Recombination Hotspot Identification Gene Fusions

Mapping chromosomal regions predisposed to recombinogenic fusion events using genomic analysis.

Fusion-Driven Metabolite Addiction Development

Identifying specific metabolites whose production becomes essential for fusion-dependent cell survival.

Fusion Gene Copy Number Variation Patterns

Investigation of how copy number alterations affect fusion gene dosage and impact downstream oncogenic signaling in diverse cancer types.

Chromatin Architecture Reorganization Fusion Events

Study of three-dimensional chromatin topology changes that facilitate or result from chromosomal translocations creating gene fusions.

Fusion-Driven Hypoxia Signaling Pathway Activation

Examination of how fusion proteins activate hypoxia-inducible factors and enhance tumor adaptation to low-oxygen microenvironments.

Intron Retention Fusion Transcript Processing

Analysis of aberrant intron retention patterns in fusion transcripts and their effects on protein translation and stability.

Fusion-Associated Chromosomal Instability Propagation

Investigation of how fusion-positive cells generate secondary chromosomal aberrations and maintain genomic instability over time.

Fusion Protein Aggregation Toxicity Mechanisms

Study of pathological protein aggregation and proteotoxic stress induced by aberrant fusion proteins in cancer cells.

RNA Secondary Structure Fusion Junction Recognition

Characterization of unique RNA secondary structures at fusion breakpoints and their role in regulatory element function.

Fusion-Driven Glycolytic Enzyme Relocalization

Analysis of how fusion proteins alter subcellular localization of metabolic enzymes to enhance Warburg effect efficiency.

Extrachromosomal DNA Fusion Gene Amplification

Investigation of eccDNA-mediated amplification mechanisms for fusion genes and their role in therapy resistance.

Fusion-Induced Secretome Remodeling Analysis

Proteomic characterization of altered secreted protein profiles in fusion-positive cancer cells affecting tumor-stroma interactions.

Fusion Breakpoint Sequence Motif Discovery

Computational identification of DNA sequence elements and structural features enriched at fusion junction sites across cancer genomes.

Fusion-Mediated RNA Localization Signaling Hubs

Study of how fusion transcripts create subcellular signaling hubs through altered RNA localization and local protein synthesis.

Fusion Protein Conformational Heterogeneity Effects

Analysis of multiple stable conformations in fusion proteins and their differential effects on protein interactions and function.

Palindromic Sequence-Mediated Fusion Formation

Investigation of palindromic DNA sequences as hotspots for illegitimate recombination generating recurrent gene fusions.

Fusion-Associated V(D)J Recombination Byproducts

Study of aberrant fusion genes arising from defective B and T cell receptor recombination machinery in hematopoietic malignancies.

Fusion Gene Horizontal Transfer Viral Vectors

Development of engineered viral vectors for delivery of fusion-targeting therapeutic sequences in gene therapy applications.

Fusion-Driven Protein Misfolding Aggregation Diseases

Investigation of neurotoxic protein aggregates formed by neurological disease-associated fusion proteins.

Multi-Exon Fusion Transcript Combinatorial Diversity

Analysis of alternative fusion transcript variants generated through combinatorial exon shuffling in single fusion events.

Fusion-Associated Long-Range Enhancer Hijacking

Study of how fusion genes aberrantly interact with distant regulatory elements creating pathologic gene expression.

RNA-Protein Fusion Hybrid Molecule Engineering

Design and characterization of artificial RNA-protein hybrid molecules derived from fusion genes for therapeutic applications.

Fusion-Mediated Mitochondrial Dysfunction Pathways

Examination of how fusion proteins alter mitochondrial function and energy metabolism in cancer cells.

Fusion Junctional Neoantigen Presentation Optimization

Engineering of fusion junctional epitopes for enhanced MHC binding and T cell receptor recognition in immunotherapy.

Transposable Element-Mediated Fusion Formation Mechanisms

Investigation of retrotransposon and DNA transposon involvement in generating breakpoints for recurrent fusion genes.

Fusion-Induced Nuclear Lamina Destabilization

Study of how fusion proteins disrupt nuclear envelope organization and affect genome stability and nuclear organization.

Fusion Gene Expression Stochastic Noise Modulation

Analysis of transcriptional noise and cell-to-cell variability in fusion gene expression affecting cellular heterogeneity.

Fusion-Associated Splicing Factor Recruitment Mechanisms

Investigation of how fusion proteins recruit abnormal splicing factor complexes to regulate transcript processing.

Fusion-Mediated Autophagy Pathway Dysregulation

Study of altered autophagy signaling in fusion-positive cells affecting protein homeostasis and survival.

Fluorescent Protein-Tagged Fusion Dynamics Imaging

Real-time visualization of fusion protein localization, interaction dynamics, and trafficking in living cells.

Fusion Gene Evolutionary Conservation Comparative Oncology

Comparative analysis of fusion genes across mammalian species to identify conserved oncogenic mechanisms.

Fusion-Associated Ferroptosis Resistance Mechanisms

Investigation of how fusion proteins confer resistance to iron-dependent cell death pathways in cancer cells.

Fusion Transcript UTR-Mediated Regulatory Elements

Characterization of functional regulatory sequences in fusion transcript untranslated regions affecting mRNA stability and translation.

Fusion-Driven Senescence Evasion Mechanisms

Study of how fusion proteins bypass replicative senescence checkpoints enabling unlimited cellular proliferation.

Cell-Free DNA Fusion Detection Circulating Biomarkers

Development of sensitive methods for fusion gene detection in circulating cell-free DNA for non-invasive cancer monitoring.

Fusion Protein Prion-Like Propagation Properties

Investigation of whether fusion proteins exhibit self-propagating conformational changes between cells.

Fusion-Mediated Lipid Metabolism Reprogramming

Analysis of altered fatty acid synthesis and lipid composition in fusion-positive cancer cell membranes and signaling.

Fusion Gene Breakpoint Nucleotide Sequencing Consensus

Genome-wide identification of nucleotide bias and sequence context patterns at fusion breakpoint boundaries.

Fusion-Associated Stress Granule Formation Dynamics

Study of aberrant stress granule assembly induced by fusion proteins affecting translation and RNA stability.

Engineered Fusion Protein Substrate Specificity Tuning

Rational design of fusion proteins with altered substrate recognition and catalytic specificity for research and therapeutic purposes.

Fusion-Mediated Wnt Signaling Pathway Hyperactivation

Mechanistic investigation of how specific fusion proteins constitutively activate Wnt signaling cascades in cancer.

Fusion Gene Breakpoint Electron Microscopy Visualization

Ultra-high-resolution structural characterization of chromosomal breakpoint regions involved in fusion gene formation.

Fusion-Driven Notch Signaling Dysregulation

Analysis of how fusion proteins aberrantly activate or inhibit Notch pathway components affecting cell fate determination.

Fusion Transcript Stability Element Discovery

Identification of RNA sequence elements that stabilize or destabilize fusion transcripts in cellular environments.

Fusion-Associated Immune Tolerance Establishment

Investigation of mechanisms by which fusion-positive tumors establish immune tolerance and evade anti-tumor responses.

Fusion Protein Crystal Structure High-Resolution Determination

X-ray crystallography and cryo-EM structural characterization of clinically relevant oncogenic fusion proteins.

Fusion-Mediated Hedgehog Pathway Aberrant Activation

Study of how fusion proteins dysregulate Hedgehog signaling components affecting developmental pathways in cancer.

Fusion Gene Expression Single-Cell Transcriptomics Analysis

Single-cell RNA-seq characterization of fusion gene expression heterogeneity and associated transcriptional signatures.

Fusion-Associated DNA Repair Pathway Dependencies

Identification of DNA repair mechanisms that are synthetically lethal or essential in fusion-positive cancer cells.

Fusion Protein Allosteric Regulation Mechanisms

Investigation of allosteric sites and conformational changes in fusion proteins as targets for therapeutic inhibition.

Fusion-Driven Nutrient Sensing mTOR Pathway

Analysis of how fusion proteins dysregulate nutrient sensing and mTOR signaling in cancer cell metabolism.

Fusion Gene Breakpoint Epigenetic Modification Landscape

ChIP-seq and ATAC-seq characterization of histone modifications and chromatin accessibility at fusion breakpoint regions.

Fusion-Driven Chromatin Architecture Remodeling

Investigation of how gene fusion proteins alter three-dimensional chromatin organization and long-range chromosomal interactions to drive oncogenic transcription.

In Vivo Fusion Gene Editing Strategies

Development of systemic delivery approaches for selective removal or correction of fusion genes within animal models using advanced editing technologies.

Fusion-Associated Extracellular Vesicle Signaling

Characterization of how fusion proteins packaged in exosomes and microvesicles propagate malignant signaling between tumor cells and stromal components.

Allosteric Modulation Fusion Protein Kinetics

Design of allosteric inhibitors that selectively target conformational states unique to fusion kinase proteins without affecting wildtype enzyme activity.

Fusion-Mediated Ribosome Biogenesis Dysregulation

Analysis of how fusion transcription factors deregulate nucleolar function and ribosomal RNA processing to enhance translation capacity in fusion-positive tumors.

Spatial Transcriptomics Fusion Junction Resolution

Application of high-resolution spatial RNA sequencing to map fusion transcript distribution and microenvironmental context within intact tissue sections.

Fusion Protein Prion-Like Aggregation Phenomena

Investigation of self-propagating fusion protein aggregates that exhibit prion-like characteristics and drive cell-to-cell transmission of malignant phenotypes.

Circulating Tumor DNA Fusion Fragment Profiling

Development of ultra-sensitive methods to detect and quantify fusion-specific cfDNA fragments for real-time monitoring of fusion-positive malignancies.

Fusion-Induced Viral Mimicry Response Pathways

Characterization of how fusion gene products trigger interferon-stimulated gene expression through viral pattern recognition receptor activation.

Machine-Learning Fusion Prediction Genomic Models

Development of deep learning algorithms integrating genomic context and chromosomal fragility data to predict fusion susceptibility across cancer types.

Fusion Protein Compartmentalization Targeting Peptides

Engineering of minimal targeting sequences that redirect fusion proteins to specific cellular compartments to alter their oncogenic activity.

Hypermethylation Patterns Fusion Gene Promoters

Analysis of CpG methylation changes at fusion gene regulatory regions and their role in modulating fusion transcript expression heterogeneity.

Fusion-Driven Metabolic Enzyme Relocalization

Study of how fusion protein localization signals misroute metabolic enzymes to altered subcellular sites, creating metabolic compartmentalization advantages.

Single-Cell Fusion Gene Expression Heterogeneity

Application of single-cell RNA-seq and proteomics to reveal clonal and phenotypic heterogeneity in fusion transcript and protein expression within tumors.

Fusion-Associated Histone Modification Landscapes

Genome-wide mapping of histone post-translational modifications at fusion-regulated loci to identify epigenetic dependencies for fusion-driven transcription.

Bacterial Artificial Chromosome Fusion Models

Generation of transgenic organisms expressing fusion genes from BAC constructs to study biological consequences in physiological developmental contexts.

Fusion Protein Membrane Trafficking Regulation

Investigation of endocytic, exocytic, and autophagy pathways that control fusion protein recycling and clearance dynamics.

Proteolytic Cleavage Fusion Protein Activation

Identification of protease-dependent processing events that generate bioactive fusion protein fragments with distinct signaling properties.

Fusion-Positive Patient-Derived Xenograft Models

Establishment and characterization of primary fusion-positive tumor xenografts preserving heterogeneity for therapeutic testing and mechanistic validation.

Targeted Nanotherapy Fusion-Specific Delivery

Development of fusion junction-targeting nanoparticles that selectively deliver cytotoxic or immunomodulatory payloads to fusion-positive cells.

Fusion Transcript Stability RNA-Binding Proteins

Identification of RNA-binding protein dependencies that control fusion transcript half-life and localization for therapeutic targeting opportunities.

Non-Homologous End Joining Fusion Mechanism Analysis

Mechanistic study of NHEJ pathway components facilitating aberrant joining events that generate recurrent fusion breakpoints.

Fusion-Associated Metabolic Flux Reprogramming

Isotope tracing and metabolic modeling revealing how fusion proteins rewire central carbon metabolism and biosynthetic pathway dependencies.

Immunopeptidomics Fusion-Derived HLA Peptides

Mass spectrometry-based identification of MHC-presented fusion-specific peptides for personalized neoantigen-based immunotherapy development.

Fusion Protein Structural Plasticity Dynamics

Cryo-EM and molecular dynamics simulations revealing conformational flexibility of fusion proteins and its role in protein-protein interaction selectivity.

Chromosome Segregation Defects Fusion Origins

Investigation of mitotic errors and aneuploidy-induced mechanisms generating fusion events during aberrant chromosome segregation cycles.

Fusion-Driven Angiogenic Signaling Axis

Characterization of how fusion proteins stimulate VEGF, FGF, and angiopoietin pathways to promote neovascularization and vascular permeability.

Engineered T-Cell Receptor Fusion Recognition

Design of T-cell receptors and TCR-engineered T-cells targeting fusion junction-derived peptide epitopes for adoptive cell therapy.

Fusion-Associated Genomic Rearrangement Signatures

Bioinformatic analysis of whole-genome structural variation patterns distinguishing fusion-generating mechanisms and their associated mutational contexts.

Fusion Protein Translation Efficiency Regulation

Study of ribosomal scanning, reinitiation, and IRES-dependent mechanisms controlling fusion transcript translation rates and protein output.

Optical Biosensor Fusion Detection Platforms

Development of real-time fluorescence or surface plasmon resonance biosensors for label-free detection of fusion genes in clinical samples.

Fusion-Positive Cell Line Genomic Characterization

Comprehensive multi-omics profiling of established fusion-positive cell lines to enable mechanistic discovery and standardized experimental models.

Fusion Protein Post-Translational Modification Atlas

Comprehensive mapping of phosphorylation, acetylation, ubiquitination, and glycosylation sites on fusion proteins governing their activity and localization.

Fusion-Mediated DNA Methyltransferase Recruitment

Investigation of how fusion transcription factors aberrantly recruit DNMT complexes causing hypermethylation of tumor suppressor genes.

Breakpoint Junction PCR Assay Standardization

Development of validated multiplex PCR platforms for rapid clinical detection of recurrent fusion breakpoints with standardized protocols.

Fusion Protein Dominant-Negative Activity Mechanisms

Characterization of how fusion proteins sequester or inhibit wildtype partner proteins through competitive binding or transposon activities.

Synthetic Biology Fusion Protein Circuit Design

Engineering of synthetic signaling circuits incorporating fusion protein components for controlled therapeutic activation in response to disease markers.

Fusion-Associated Mutagenic DNA Repair Pathways

Study of error-prone DNA repair mechanisms activated by fusion proteins that generate secondary mutations and increase genomic instability.

Organelle-Specific Fusion Protein Localization Prediction

Development of computational models predicting fusion protein trafficking to mitochondria, peroxisomes, ER, and other organelles based on chimeric structure.

Fusion-Driven Splicing Factor Dependency Networks

Identification of SR proteins and splicing factors whose activity is essential for fusion transcript processing and oncogenic isoform generation.

Fluorescent Protein Fusion Detection Microscopy

Application of complementary fluorescent protein systems to visualize fusion events at single-cell resolution in living and fixed specimens.

Fusion-Positive Leukemia Remission Monitoring

Development of minimal residual disease assays targeting fusion transcripts for early detection of relapse in fusion-positive hematologic malignancies.

Cross-talk Fusion Protein Signaling Cascades

Analysis of how fusion kinase activation triggers multiple parallel signaling pathways through shared substrates and scaffold protein interactions.

DNA Fragility Sites Fusion Breakpoint Hotspots

Identification of common fragile sites and replication stress regions predisposing to double-strand breaks that generate recurrent fusions.

Fusion Protein Interactome Rewiring Cancer Phenotypes

Comparative proteomics revealing how fusion proteins acquire novel binding partners that drive transformation compared to wildtype protein interactions.

Bacterial Toxin-Antitoxin Fusion-Selective Killing

Engineering of fusion junction-responsive toxin-antitoxin systems for selective elimination of fusion-positive cells in genetic therapy approaches.

Fusion-Associated Replication Timing Program Changes

Analysis of altered S-phase timing patterns at fusion loci and their effects on fusion gene expression levels and genomic stability.

Aptamer-Based Fusion Protein Biosensors

Selection of RNA and DNA aptamers targeting fusion-specific epitopes for diagnostic and therapeutic applications in clinical detection.

Fusion Gene Integration Site Analysis Sequencing

High-throughput sequencing of chromosomal regions flanking fusion breakpoints to identify cis-acting elements and integration mechanism patterns.

Fusion-Positive Tumor Heterogeneity Single-Cell Atlas

Multi-modality single-cell analysis generating comprehensive atlases of cellular diversity, clonal structure, and microenvironmental composition in fusion-driven tumors.

Fusion Breakpoint Sequencing High-Throughput Validation

Development and optimization of next-generation sequencing methodologies for precise identification and validation of fusion gene breakpoint junctions across diverse cancer types.

Fusion Protein Conformational Changes Real-Time Monitoring

Utilization of single-molecule fluorescence and cryo-EM techniques to characterize dynamic conformational transitions in fusion proteins under physiological conditions.

Fusion-Driven Chromosomal Instability Amplification Pathways

Investigation of mechanisms by which initial fusion events trigger cascading chromosomal rearrangements and sustained genomic instability in transformed cells.

Non-Canonical Fusion Junction Processing Mechanisms

Characterization of alternative splicing and post-translational modifications occurring at fusion gene junctions that generate functional protein diversity.

Fusion-Positive Extracellular Vesicle Biomarkers Development

Discovery and validation of fusion protein-containing exosomes and microvesicles as non-invasive diagnostic and prognostic biomarkers in patient blood and bodily fluids.

Spatial Transcriptomics Fusion Gene Distribution Mapping

Application of spatial RNA sequencing to determine three-dimensional distribution patterns of fusion transcripts within tumor tissue heterogeneity.

Fusion Protein Allosteric Regulation Drug Targeting

Discovery of allosteric binding sites on fusion proteins that enable novel small-molecule inhibition strategies circumventing kinase domain mutations.

Ancestral Fusion Event Reconstruction Phylogenetic Analysis

Computational and experimental investigation of evolutionary origins and conservation patterns of recurrent fusion genes across primate species.

Fusion-Associated Metabolic Enzyme Complex Assembly

Structural and biochemical characterization of aberrant metabolic enzyme complexes formed through fusion protein incorporation into cellular metabolic pathways.

Minority Fusion Clone Detection Sensitive Methods

Development of ultra-sensitive detection platforms achieving single-cell level identification of minor fusion-positive clones in mixed tumor populations.

Fusion Protein RNA-Binding Domain Functionality

Investigation of transcriptome-wide RNA targets and regulatory networks controlled by RNA-binding domains acquired through gene fusion events.

Fusion-Driven Tumor Evolution Mathematical Modeling

Development of stochastic computational models predicting clonal dynamics and selective advantages conferred by fusion events during multi-stage tumorigenesis.

Fusion Peptide Immunogenicity HLA-Peptide Binding

Systematic assessment of MHC-peptide binding affinities and T-cell receptor recognition for fusion junction-spanning epitopes across diverse HLA backgrounds.

Fusion-Positive Cell Line Characterization Resource Development

Comprehensive genomic, proteomic, and functional profiling of fusion-positive cancer cell lines to establish standardized research resources and reference materials.

Domain-Interface Specific Fusion Protein Stabilization

Design and optimization of stabilizing mutations and chemical stabilizers targeting specific domain interfaces created by fusion protein architecture.

Fusion-Driven Dormancy Reactivation Mechanisms

Elucidation of signaling pathways controlling dormancy exit in fusion-positive minimal residual disease and mechanisms enabling therapeutic resistance.

Inter-Fusion Protein Interaction Networks Mapping

Co-immunoprecipitation and proximity labeling studies defining interaction networks between multiple fusion proteins occurring in the same tumor.

Fusion Gene Synthetic Lethality Screen Integration

Genome-wide CRISPR and RNAi screens identifying fusion-specific synthetic lethal gene combinations for rational multi-drug therapeutic design.

Fusion-Positive Tumor Immune Infiltration Determinants

Systematic investigation of factors controlling T-cell and myeloid infiltration patterns specifically in fusion-driven malignancies versus wild-type tumors.

Fusion Protein Degradation Kinetics Optimization

Rational design of protein destabilizing degrons enhancing proteasomal and autophagosomal degradation rates of pathogenic fusion proteins.

Circulating Tumor DNA Fusion Mutation Tracking

Development of ultra-sensitive ctDNA assays enabling longitudinal monitoring of fusion allele burden as dynamic biomarkers for treatment response assessment.

Fusion-Associated Aberrant Splicing Isoform Networks

Deep sequencing of fusion-positive tumors revealing global splicing dysregulation networks and production of pathogenic protein isoforms.

Fusion Protein Structural Optimization Computational Design

Machine learning-guided protein engineering improving stability, solubility, and potency of recombinant fusion proteins for therapeutic applications.

Fusion Junction Immunofluorescence Multiplex Detection

Development of proximity-dependent and fluorophore-conjugated antibodies enabling high-resolution subcellular visualization of multiple fusion proteins simultaneously.

Fusion-Driven Tumor Microenvironment Fibroblast Activation

Investigation of paracrine signaling by fusion-positive cancer cells inducing cancer-associated fibroblast differentiation and extracellular matrix remodeling.

Patient-Derived Fusion Xenograft Model Development

Establishment and characterization of patient-derived xenograft models maintaining fusion gene architecture for personalized treatment response prediction.

Fusion Protein Aggregation Propensity Prediction

Development of bioinformatic algorithms predicting aggregation-prone regions in fusion proteins guiding rational design of soluble variants.

Fusion-Associated Phosphorylation Signaling Cascades

Phosphoproteomics-driven mapping of downstream signaling networks activated by fusion kinases identifying vulnerabilities for kinase inhibitor combination therapy.

Pangenomic Fusion Variant Classification Standards

Establishment of evidence-based classification frameworks for fusion variants incorporating cancer type, in-frame status, and functional validation data.

Fusion Protein Membrane Targeting Localization Sequences

Characterization of targeting signals and membrane association mechanisms acquired through fusion of transmembrane domains with cytoplasmic proteins.

Fusion-Positive Leukemia Hematopoietic Stem Cell Origin

Investigation of hematopoietic stem and progenitor cell differentiation stages at which fusion events initiate acute leukemia development.

Fusion Gene Regulatory Element Enhancer Hijacking

Identification and characterization of ectopic super-enhancer elements brought into proximity by fusion translocations driving oncogenic expression patterns.

Monoclonal Antibody Fusion-Specific Epitope Engineering

Systematic development of high-affinity monoclonal antibodies recognizing fusion junction epitopes with minimal cross-reactivity to wild-type proteins.

Fusion Protein Post-Translational Modification Landscape

Mass spectrometry-based characterization of phosphorylation, acetylation, ubiquitination and glycosylation patterns unique to fusion proteins.

Fusion-Driven Metabolic Addiction Biomarker Discovery

Metabolomic and fluxomic analysis of fusion-positive tumors identifying metabolic dependencies amenable to combination metabolic and targeted therapies.

Fusion Protein Structural Variants Functional Impact

Experimental validation of structural predictions for protein variants arising from alternative fusion breakpoints determining functional and clinical consequences.

Fusion-Positive Cancer Stemness Gene Expression Signatures

Single-cell RNA sequencing identifying fusion-dependent stemness gene signatures and developmental trajectories in fusion-positive tumors.

Fusion Gene Promoter Structural Organization Analysis

Chromatin immunoprecipitation and ATAC-seq studies revealing promoter accessibility and transcription factor binding at fusion gene regulatory regions.

Fusion-Associated Drug Transporter Upregulation Mechanisms

Investigation of fusion protein-driven expression of drug efflux pumps and metabolic enzymes contributing to therapeutic drug resistance.

Fusion Protein Chimeric Domain Functional Validation

Systematic mutagenesis and biochemical assays determining which parent protein domains remain functional in fusion context.

Fusion-Positive Tumor Genomic Instability Signatures

Characterization of mutational signatures, copy number alterations, and structural variation patterns associated with specific fusion-positive cancer types.

Fusion Protein Therapeutic Antibody Combination Strategies

Optimization of bispecific and multispecific antibody designs enabling simultaneous targeting of fusion proteins and complementary immune checkpoint molecules.

Fusion-Driven Angiogenesis Vascular Remodeling Pathways

Investigation of VEGF and hypoxia-independent angiogenic mechanisms specifically activated by fusion oncoproteins in tumor vasculature.

Fusion Gene Expression Noise Stochastic Dynamics

Single-cell fluorescence microscopy and RNA quantification revealing burst kinetics and expression variability of fusion transcripts across clonal populations.

Fusion Protein Therapeutic Vaccine Neoantigen Design

Rational design of personalized cancer vaccines encoding fusion junction neoantigens with optimized immunogenicity and reduced self-tolerance.

Fusion-Positive Relapsed Disease Clonal Evolution Analysis

Deep sequencing and phylogenetic analysis of resistant clones arising during fusion-positive leukemia relapse revealing genetic hits in fusion backgrounds.

Fusion Protein Interactome Dynamic Reorganization

Time-resolved proteomics mapping changes in fusion protein interaction partners during cell cycle progression and differentiation.

Fusion-Associated Chromosomal Rearrangement Prediction Models

Computational prediction of secondary structural variants and recurrent rearrangement hotspots emerging in fusion-driven tumors.

Fusion Protein Therapeutic Resistance Biomarker Panel

Development of multi-modal biomarker assays predicting resistance to fusion-targeted therapies incorporating mutation, expression, and epigenetic markers.

Fusion Gene Copy Number Amplification Mechanisms

Investigation of selective pressures and mechanistic pathways driving focal amplification of fusion genes in secondary genomic events.

Fusion-Driven Chromatin Architecture Reorganization

Investigation of how gene fusion proteins alter three-dimensional chromatin structure and nuclear organization to establish aberrant transcriptional landscapes and disease phenotypes.